Robert A. Bradway (CEO of Amgen)

Robert A. Bradway is the CEO of Amgen, a leading biotechnology company that develops medicines to treat serious illnesses like cancer, kidney disease, and inflammatory conditions. He oversees the company's strategy, research, and operations, ensuring the development of innovative therapies that improve patient lives. With a background in finance and healthcare, Bradway has guided Amgen through scientific advancements and industry challenges, emphasizing innovation and responsible growth. His leadership focuses on leveraging science to address unmet medical needs, while maintaining ethical standards and delivering value to patients, healthcare providers, and shareholders.